Cancer Detection and Cancer Characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) – Section Rotterdam
Authors:
- Fritz H. SchröderFSFritz H. Schröder
- Monique J. RoobolMonique J. Roobol
- Theodorus H. van der KwastTKTheodorus H. van der Kwast
- 1 July 2007
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 52 (1) , 89-97
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- 4-YEAR PROSTATE SPECIFIC ANTIGEN PROGRESSION AND DIAGNOSIS OF PROSTATE CANCER IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER, SECTION ROTTERDAMJournal of Urology, 2005
- CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTSJournal of Urology, 2004
- Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinomaCancer, 2004
- The story of the European Randomized Study of Screening for Prostate CancerBJU International, 2003
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trialInternational Journal of Cancer, 2001
- Processing Radical Prostatectomy Specimens: A Comprehensive and Standardized ProtocolJournal of Urologic Pathology, 1998
- Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancerWorld Journal of Urology, 1997
- The TNM classification of prostate cancerThe Prostate, 1992